Evidence map›Paper›PMID 35123506›Full record

ArticleJournal of translational medicine2022

Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases.

Zhen Wang, Ruoying Yu, Xiaoxi Chen, Hua Bao, Ran Cao, An-Na Li, Qiuxiang Ou, Hai-Yan Tu, Qing Zhou, Xue Wu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Zhen WangGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Lung Cancer Institute, Zhong Shan 2nd road 106, Guangzhou, 510080, Guangdong, China. wangzhen@gdph.org.cn.ORCID 0000-0002-4456-8752
Ruoying YuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Xiaoxi ChenGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Hua BaoGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Ran CaoGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
An-Na LiGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Lung Cancer Institute, Zhong Shan 2nd road 106, Guangzhou, 510080, Guangdong, China.
Qiuxiang OuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Hai-Yan TuGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Lung Cancer Institute, Zhong Shan 2nd road 106, Guangzhou, 510080, Guangdong, China.
Qing ZhouGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Lung Cancer Institute, Zhong Shan 2nd road 106, Guangzhou, 510080, Guangdong, China.
Xue WuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
Zhi-Bo LinGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Lung Cancer Institute, Zhong Shan 2nd road 106, Guangzhou, 510080, Guangdong, China.
Yi-Long WuGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Lung Cancer Institute, Zhong Shan 2nd road 106, Guangzhou, 510080, Guangdong, China.
Guangdong Academy of Medical Sciences · CN

Funding

CSCO Research Fund Y-2019AZMS-0034CSCO-Roche Research Fund Y-2019Roche-022Guangzhou Science and Technology Project 201804010477Public Interest by National Health and Family Control Committee 201402031
6 · The paper itself

Abstract

backgroundFree circular RNAs(circRNAs) escaping from primary lesion of cancer to brain are strictly regulated by blood-brain barrier and therefore cerebrospinal fluid (CSF) circRNAs have potential advantage in exploring biomarkers and mechanism of brain metastasis in lung cancer.

methodsWe collected paired cerebrospinal fluid, plasma and tumor tissues from 21 lung adenocarcinoma (ADC) patients with brain metastases (BM) and performed RNA sequencing.

resultsCompared to tumor tissue and plasma, circRNAs in CSF were characterized by lower number of spieces but higher abundance. Notably, CSF-circRNAs displayed high heterogeneity among different BM lung ADC patients. A total of 60 CSF-circRNAs was identified and associated with shorten overall survival. The circRNA-miRNA-mRNA network analysis revealed that the 60 CSF-circRNAs involved in cancer-associated pathways, and five of them showed strong association with WNT signaling pathway. Validation by RT-PCR of CSF and in vitro experiments of the five candidate circRNAs support their potential roles in cell proliferation and invasion.

conclusionsIn summary, our results depicted the heterogenous CSF-circRNAs profiles among BM lung ADC and implied that CSF-circRNAs may be promising prognosis-related biomarkers.

Indexed as

Adenocarcinoma of LungBrain NeoplasmsLung NeoplasmsMicroRNAsHumansRNA, CircularMicroRNAsRNA, CircularCerebrospinal fluidCircular RNALung ADC brain metastasisOverall survival

Identifiers

PMID35123506
PMCPMC8818222
OpenAlexW4212764937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.